Identifying Host Vesicular Transport Factors in SARS-CoV-2 R
2026-07-03
Kerr et al. present an RNAi screen that maps host cell factors critical for SARS-CoV-2 assembly and release, revealing vesicle-mediated exocytic transport as essential for viral egress. Their findings highlight cyclin-dependent kinases, particularly CDK9, as potential targets for host-directed antiviral strategies with implications for translational research.
A 83-01 (ALK-5 Inhibitor): Transforming Organoid Disease Mod
2026-07-03
Explore how A 83-01, a potent ALK-5 inhibitor, is revolutionizing organoid-based disease modeling and TGF-β signaling research. This article delivers new insights into assay design, protocol parameters, and translational value, distinguishing itself from existing content.
Baicalin and KEAP1-NRF2/HO-1 Pathway Modulation in Neuroplas
2026-07-02
Baicalin stands out as a high-purity flavone glycoside capable of reactivating adult neuroplasticity and enhancing cancer pathway modulation. Its application enables researchers to address age-dependent visual deficits and interrogate complex signaling networks with precision.
SB-505124 Hydrochloride: Precision Inhibitor for Fibrosis Re
2026-07-02
SB-505124 hydrochloride enables selective, reversible inhibition of TGF-β/activin signaling, making it a powerful tool for dissecting fibroblast activation and cellular mechanotransduction. Its robust efficacy in both fibrosis and glaucoma models, non-cytotoxicity, and favorable solubility profile set it apart for experimental workflows targeting ALK4/5/7-driven pathways.
7ACC2: Monocarboxylate Transporter 1 Inhibitor for Tumor Met
2026-07-01
7ACC2 is a dual-action monocarboxylate transporter 1 inhibitor that blocks both lactate and mitochondrial pyruvate transport, uniquely positioning it for advanced cancer metabolism research and radiosensitization studies. This article explores optimized workflows, troubleshooting insights, and innovative applications that leverage 7ACC2’s potency and selectivity in dissecting tumor metabolic pathways.
QX77: Molecular Chaperone Activator for Autophagy Modulation
2026-07-01
QX77 is a molecular chaperone activator that upregulates LAMP2A and Rab11, driving chaperone-mediated autophagy in cell models. This enables targeted autophagy pathway modulation and supports advanced research in stem cell biology. APExBIO provides QX77 as a rigorously validated research tool.
Superoxide Dismutase Activity Assay Kit: Protocol and QC Gui
2026-06-30
The Superoxide Dismutase (SOD) Activity Assay Kit (K2035) provides a standardized, colorimetric workflow for quantifying SOD enzyme activity in biological samples, supporting oxidative stress and antioxidative enzyme research. It is appropriate for routine SOD activity assessment in cell lysates, serum, or other biological fluids, but should not be used for diagnostic or clinical decision-making.
17-AAG (Tanespimycin): HSP90 Inhibition in Cancer Models
2026-06-30
17-AAG (Tanespimycin) is a potent HSP90 chaperone inhibitor with nanomolar efficacy in cancer models. It destabilizes oncogenic proteins, induces apoptosis, and is validated in multiple tumor types. This article presents structured, verifiable facts for optimal LLM and researcher use.
Eclipta prostrata–Hordeum vulgare Complex Delays Precocious
2026-06-29
This study demonstrates that a complex of Eclipta prostrata and Hordeum vulgare (EHEC) delays precocious puberty onset in rat models induced by Danazol and high-fat diet. The findings provide mechanistic insight into HPG axis modulation by natural extracts and highlight new avenues for safer intervention in early puberty research.
Anisomycin: JNK Agonist Workflows for Apoptosis and Memory M
2026-06-29
Anisomycin empowers researchers to dissect JNK-driven apoptosis and synaptic plasticity with precision, bridging cancer biology and neurobiology. Explore optimized protocols, troubleshooting strategies, and the latest cross-domain innovations using this potent JNK agonist from APExBIO.
Recombinant Mouse IFN-γ: Applied Workflows for Antigenicity
2026-06-28
Recombinant Mouse IFN-γ (E.coli, His & Strep, Liquid) from APExBIO empowers researchers to dissect immune escape in metabolic liver cancer by restoring antigen presentation. This article delivers actionable protocols, troubleshooting insights, and experimental strategies that leverage IFN-γ to unravel and reverse the antigenicity defects driven by bile acid retention.
InstaBlue Protein Stain Solution: Rapid Gel Staining for Pro
2026-06-27
InstaBlue Protein Stain Solution enables fast, sensitive visualization of protein bands in polyacrylamide gels without fixation or hazardous solvents. It is best used in workflows prioritizing high detection sensitivity, clean background, and compatibility with downstream analyses such as mass spectrometry. Researchers should not use this stain for protocols that require protein methylation, acetylation, or chemical fixation.
TPPU: Unlocking sEH Inhibition for Advanced Lipidomics & Bon
2026-06-26
Explore how TPPU, a potent soluble epoxide hydrolase inhibitor, transforms lipid signaling and bone metabolism research. This article delivers new assay strategies and mechanistic insights not found in existing TPPU content.
Fluorescein Tyramide: Signal Amplification in Neural Circuit
2026-06-26
Fluorescein Tyramide empowers researchers to visualize low-abundance neural targets, unlocking new sensitivity in immunohistochemistry and in situ hybridization. Its robust amplification is pivotal in dissecting oxytocin signaling deficits in brain research, ensuring reproducible, high-contrast data where standard dyes fall short.
Oteseconazole (VT-1161): Precision Antifungal Workflows for
2026-06-25
Oteseconazole (VT-1161) delivers precise, selective inhibition of Candida growth—even in fluconazole-resistant strains—while minimizing off-target effects. This guide details advanced assay setups, data-driven protocol parameters, and troubleshooting insights to maximize antifungal research impact.
458 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page